Redhill Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Jun 23

EPS

$-0.030

Quarterly Revenue

$18.2M

Annual Revenue (as of Dec 31)

$22.1M

Earnings Recap

Redhill Biopharma (NASDAQ:RDHL) reported its Q1 earnings results on Thursday, June 23, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Redhill Biopharma reported an EPS of $0.03.

Revenue was down $2.34 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.28 which was followed by a 12.72% increase in the share price the next day.

Here's a look at Redhill Biopharma's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.33	-0.21	-0.12	-0.34
EPS Actual	-0.05	-0.50	-0.06	-0.05
Revenue Estimate	24.08M	24.52M	25.02M	22.70M
Revenue Actual	22.07M	21.61M	21.50M	20.57M

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings History

Analyze the earnings history of Redhill Biopharma using advanced sorting and filters.

Redhill Biopharma Questions & Answers

When is Redhill Biopharma (NASDAQ:RDHL) reporting earnings?

Redhill Biopharma (RDHL) is scheduled to report earnings on August 25, 2022. The last reported earnings were for reported on June 23, 2022 for Q1.

What were the latest earnings per share (EPS) for Redhill Biopharma (NASDAQ:RDHL)?

The Actual EPS was $-0.06, which beat the estimate of $-0.58.

What were Redhill Biopharma’s (NASDAQ:RDHL) revenues?

The Actual Revenue was $483K, which beat the estimate of $220K.

Browse earnings estimates, EPS, and revenue on all stocks.

QQQ

DIA

SPY

TLT

GLD

BTC/USD

QQQ

DIA

SPY

TLT

GLD